Medtronic plc (LON:0Y6X)
88.09
-1.14 (-1.28%)
Mar 28, 2025, 7:12 PM BST
Medtronic Revenue
Medtronic had revenue of $8.29B USD in the quarter ending January 24, 2025, with 2.51% growth. This brings the company's revenue in the last twelve months to $33.20B, up 2.72% year-over-year. In the fiscal year ending April 26, 2024, Medtronic had annual revenue of $32.36B with 3.64% growth.
Revenue (ttm)
$33.20B
Revenue Growth
+2.72%
P/S Ratio
n/a
Revenue / Employee
$349.46K
Employees
95,000
Market Cap
86.82B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
Apr 26, 2019 | Pro | Pro | Pro |
Apr 27, 2018 | Pro | Pro | Pro |
Apr 28, 2017 | Pro | Pro | Pro |
Apr 29, 2016 | Pro | Pro | Pro |
Apr 24, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Medtronic News
- 11 days ago - Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy - Seeking Alpha
- 12 days ago - FDA classifies recall of Medtronic embolization devices as 'most serious' - Reuters
- 13 days ago - Dividend Kings Of The Future - Seeking Alpha
- 13 days ago - Medtronic slips after FDA notice on product recall - Seeking Alpha
- 13 days ago - Medtronic (MDT) Announces Transition of Principal Accounting Officer - GuruFocus
- 21 days ago - CGS Transforms Workplace Training with Cicero, a New AI-Driven, Customizable Roleplay Platform - GlobeNewsWire
- 21 days ago - Medtronic PLC (MDT) Announces Promising Two-Year Results from SMART Trial - GuruFocus
- 21 days ago - SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients - PRNewsWire